Yatin Suneja Analyst PerformanceBiotechnology Research Analyst - Specializes in I&I, CNS at GuggenheimYatin Suneja is a stock analyst at Guggenheim in the medical sector, covering 44 publicly traded companies. Over the past year, Yatin Suneja has issued 79 stock ratings, including strong buy, buy, and hold recommendations. While full access to Yatin Suneja's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Yatin Suneja's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings144 Last 10 YearsBuy Recommendations86.81% 125 Buy RatingsCompanies Covered44 Unique Companies Ratings Distribution144RatingsDistribution of strong buy, buy, hold, and sell ratings by Yatin Suneja.RatingPercentageCount Strong Buy0.7%1 ratings Buy86.1%124 ratings Hold13.2%19 ratings Sell0.0%0 ratingsOut of 144 total stock ratings issued by Yatin Suneja at Guggenheim, the majority (86.1%) have been Buy recommendations, followed by 13.2% Hold and 0.7% Strong Buy.Best & Worst CallsBest Call0000.0%ALMSJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AXSMApr 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ97.7% of companies on NASDAQ43 companiesNYSE2.3% of companies on NYSE1 companyYatin Suneja, an analyst at Guggenheim, currently covers 44 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical44 companies100.0%Yatin Suneja of Guggenheim specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE36 companies81.8%MED - DRUGS5 companies11.4%PHARMACEUTICAL PREPARATIONS2 companies4.5%BIOTECHNOLOGY1 company2.3% About Yatin SunejaMr. Suneja is a Senior Managing Director and Equity Research Analyst covering the Biotechnology sector, with over 16 years of experience in equity research. Since joining Guggenheim in 2018, he has provided in-depth analysis and investment insights on biotechnology companies, with a particular focus on those in the immunology, neurology, and inflammatory (INI) space. Previously, he was a Managing Director at SunTrust Robinson Humphrey and a Vice President at Cowen & Company, both specializing in biotechnology equity research. He began his career in Corporate Banking at Bank of America. Mr. Suneja holds an M.B.A. from Syracuse University and a B.Com from PGDAV College, University of Delhi.Follow on LinkedIn Yatin Suneja's Ratings History at Guggenheim Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsEYPTEyepoint Pharmaceuticals6/24/2026Reiterated Rating$14.55$68.00Buy$0.0000.00% ROICLYMClimb Bio6/8/2026Initiated Coverage$10.55$35.00Buy$0.0000.00% ROICLYMClimb Bio6/8/2026Initiated Coverage$10.77$35.00Buy$0.0000.00% ROIOCSOculis6/1/2026Lower Price Target$22.70$45.00Buy$0.0000.00% ROIROIVRoivant Sciences5/26/2026Boost Price Target$29.96$36.00Buy$0.0000.00% ROIIMVTImmunovant5/26/2026Boost Price Target$34.15$62.00Buy$0.0000.00% ROIOCSOculis5/20/2026Initiated Coverage$27.91$75.00Buy$0.0000.00% ROIOCSOculis5/20/2026Upgrade$31.00Strong-Buy$0.0000.00% ROIALMSAlumis5/15/2026Boost Price Target$24.63$34.00Buy$0.0000.00% ROIARGXargenex5/8/2026Boost Price Target$787.31$1,135.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. NBIXNeurocrine Biosciences5/6/2026Reiterated Rating$144.75$175.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics5/4/2026Boost Price Target$227.50$260.00Buy$0.0000.00% ROIDBVTDBV Technologies5/4/2026Reiterated Rating$19.10$51.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals5/1/2026Boost Price Target$704.44$995.00Buy$0.0000.00% ROIBIIBBiogen4/30/2026Boost Price Target$194.38$260.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/27/2026Set Price Target$80.91$200.00Buy$0.0000.00% ROIIFRXInflaRx4/21/2026Reiterated Rating$1.63$14.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/13/2026Reiterated Rating$61.89$125.00Buy$0.0000.00% ROINMRANeumora Therapeutics3/31/2026Reiterated Rating$1.93$14.00Buy$0.0000.00% ROIDBVTDBV Technologies3/27/2026Reiterated Rating$20.21$51.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics3/25/2026Boost Price Target$158.75$245.00Buy$0.0000.00% ROIIMUXImmunic3/24/2026Initiated Coverage$11.70$70.00Buy$0.0000.00% ROICABACabaletta Bio3/24/2026Boost Price Target$2.70$16.00Buy$0.0000.00% ROIIFRXInflaRx3/20/2026Lower Price Target$0.91$14.00Buy$0.0000.00% ROIZBIOZenas BioPharma3/16/2026Boost Price Target$23.23$55.00Buy$0.0000.00% ROIORKAOruka Therapeutics3/13/2026Reiterated Rating$31.99$60.00Buy$0.0000.00% ROIACETAdicet Bio3/13/2026Lower Price Target$7.04$100.00Buy$0.0000.00% ROIXENEXenon Pharmaceuticals3/9/2026Reiterated Rating$62.63$90.00Buy$0.0000.00% ROISIONSionna Therapeutics3/2/2026Boost Price Target$33.68$50.00Buy$0.0000.00% ROIARGXargenex2/27/2026Lower Price Target$771.53$1,120.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals2/27/2026Boost Price Target$12.94$25.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics2/24/2026Boost Price Target$174.76$220.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines2/10/2026Reiterated Rating$319.54$800.00Buy$0.0000.00% ROIBIIBBiogen2/9/2026Boost Price Target$201.18$246.00Buy$0.0000.00% ROIIMVTImmunovant2/9/2026Boost Price Target$27.05$44.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals2/9/2026Boost Price Target$784.43$975.00Buy$0.0000.00% ROISTOKStoke Therapeutics2/5/2026Initiated Coverage$32.00$60.00Buy$0.0000.00% ROISTOKStoke Therapeutics2/5/2026Initiated Coverage$32.40$60.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics2/2/2026Initiated Coverage$15.11$50.00Buy$0.0000.00% ROIRAPTRapt Therapeutics1/20/2026Downgrade$57.52Neutral$0.0000.00% ROITicker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.👉 Unlock the ticker now and get it completely free.ALMSAlumis1/7/2026Boost Price Target$16.23$32.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics1/2/2026Reiterated Rating$177.09$205.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/29/2025Reiterated Rating$301.40Buy$0.0000.00% ROISABSSAB Biotherapeutics12/19/2025Initiated Coverage$3.95$15.00Buy$0.0000.00% ROISABSSAB Biotherapeutics12/19/2025Initiated Coverage$3.84$15.00Buy$0.0000.00% ROIIMVTImmunovant12/18/2025Reiterated Rating$26.98$41.00Buy$0.0000.00% ROIANABAnaptysBio12/18/2025Reiterated Rating$45.60Buy$0.0000.00% ROIABVXAbivax12/18/2025Reiterated Rating$110.82$175.00Buy$0.0000.00% ROIDBVTDBV Technologies12/17/2025Reiterated Rating$17.98$51.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines12/9/2025Reiterated Rating$270.98$760.00Buy$0.0000.00% ROIDBVTDBV Technologies12/3/2025Initiated Coverage$12.90$35.00Buy$0.0000.00% ROIDBVTDBV Technologies12/3/2025Initiated Coverage$12.99$35.00Buy$0.0000.00% ROIROIVRoivant Sciences11/14/2025Reiterated Rating$20.56$25.00Buy$0.0000.00% ROIIFRXInflaRx11/10/2025Boost Price Target$1.23$22.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines11/6/2025Reiterated Rating$172.35$540.00Buy$0.0000.00% ROIANABAnaptysBio11/5/2025Boost Price Target$36.13$100.00Buy$0.0000.00% ROIAXSMAxsome Therapeutics11/4/2025Boost Price Target$134.39$205.00Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals10/30/2025Reiterated Rating$13.31$20.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals10/29/2025Boost Price Target$654.48$865.00Buy$0.0000.00% ROIORKAOruka Therapeutics10/27/2025Initiated Coverage$27.25$60.00Buy$0.0000.00% ROIRAPTRapt Therapeutics10/27/2025Initiated Coverage$29.53$70.00Buy$0.0000.00% ROINMRANeumora Therapeutics10/27/2025Upgrade$2.63$14.00Buy$0.0000.00% ROIPRAXPraxis Precision Medicines10/16/2025Set Price Target$189.69$350.00Buy$0.0000.00% ROIABVXAbivax10/10/2025Boost Price Target$90.61$150.00Buy$0.0000.00% ROIACETAdicet Bio10/8/2025Boost Price Target$13.65$128.00Buy$0.0000.00% ROIMLTXMoonLake Immunotherapeutics9/30/2025Lower Price Target$6.24$20.00Buy$0.0000.00% ROIACETAdicet Bio9/19/2025Reiterated Rating$12.97$112.00Buy$0.0000.00% ROIARGXargenex9/18/2025Reiterated Rating$734.77$1,070.00Buy$0.0000.00% ROIROIVRoivant Sciences9/18/2025Boost Price Target$15.42$21.00Buy$0.0000.00% ROITRMLTourmaline Bio9/10/2025Reiterated Rating$47.64$48.00Neutral$0.0000.00% ROITRMLTourmaline Bio9/9/2025Downgrade$47.64Hold$0.0000.00% ROIDNTHDianthus Therapeutics9/9/2025Boost Price Target$31.80$100.00Buy$0.0000.00% ROIFBRXForte Biosciences8/18/2025Initiated Coverage$11.57$75.00Buy$0.0000.00% ROIFBRXForte Biosciences8/18/2025Initiated Coverage$11.49$75.00Buy$0.0000.00% ROITRMLTourmaline Bio8/14/2025Reiterated Rating$21.88$55.00Buy$0.0000.00% ROIREGNRegeneron Pharmaceuticals8/1/2025Boost Price Target$545.46$815.00Buy$0.0000.00% ROINBIXNeurocrine Biosciences8/1/2025Boost Price Target$126.03$175.00Buy$0.0000.00% ROIARGXargenex8/1/2025Boost Price Target$667.75$1,070.00Buy$0.0000.00% ROIABVXAbivax7/23/2025Boost Price Target$10.00$101.00Buy$0.0000.00% ROILRMRLarimar Therapeutics6/24/2025Reiterated Rating$2.42$26.00Buy$0.0000.00% ROIALMSAlumis6/10/2025Upgrade$3.43$18.00Buy$00.0000.00% ROIANABAnaptysBio5/28/2025Reiterated Rating$21.95$90.00Buy$00.0000.00% ROIVIGLVigil Neuroscience5/22/2025Set Price Target$7.88$8.00Neutral$0.0000.00% ROICABACabaletta Bio5/15/2025Boost Price Target$1.70$25.00Buy$0.0000.00% ROIARGXargenex5/9/2025Lower Price Target$547.89$1,065.00Buy$000.0000.00% ROIANABAnaptysBio5/6/2025Boost Price Target$20.97$54.00Buy$00.0000.00% ROINBIXNeurocrine Biosciences5/6/2025Boost Price Target$125.03$165.00Buy$000.0000.00% ROIPHATPhathom Pharmaceuticals5/2/2025Lower Price Target$2.76$12.00Buy$00.0000.00% ROIREGNRegeneron Pharmaceuticals5/1/2025Lower Price Target$589.21$810.00Buy$000.0000.00% ROIPHATPhathom Pharmaceuticals4/2/2025Reiterated Rating$5.98Buy$00.0000.00% ROIYour book attached (Ad)Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.Download the Safe Trade Options Formula book for free before access closesCABACabaletta Bio4/1/2025Reiterated Rating$1.32$23.00Buy$0.0000.00% ROIZURAZura Bio3/26/2025Reiterated Rating$1.37$15.00Buy$0.0000.00% ROIIFRXInflaRx3/26/2025Boost Price Target$1.33$10.00Buy$0.0000.00% ROILRMRLarimar Therapeutics3/25/2025Reiterated Rating$2.29$26.00Buy$0.0000.00% ROIIMVTImmunovant3/20/2025Reiterated Rating$18.84Buy$00.0000.00% ROIDNTHDianthus Therapeutics3/12/2025Reiterated Rating$23.06$84.00Buy$00.0000.00% ROIARGXargenex3/10/2025Boost Price Target$575.37$1,100.00Buy$000.0000.00% ROIIMVTImmunovant3/10/2025Reiterated Rating$20.28Buy$00.0000.00% ROINMRANeumora Therapeutics3/7/2025Downgrade$1.52Neutral$0.0000.00% ROINBIXNeurocrine Biosciences2/10/2025Lower Price Target$122.62$163.00Buy$000.0000.00% ROIIMVTImmunovant2/10/2025Lower Price Target$20.41$44.00Buy$00.0000.00% ROIVIGLVigil Neuroscience1/24/2025Reiterated Rating$2.49Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftStifel Nicolaus Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
